Results 271 to 280 of about 91,698 (296)

European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

Annals of Oncology, 2022
Ana Oaknin
exaly  

Homologous recombination deficiency testing in first-line ovarian cancer

Annals of Oncology, 2022
K N, Moore, A, du Bois
openaire   +2 more sources

Homologous Recombination Deficiency

2020
openaire   +1 more source

BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination

Nature, 2021
Jordan Robert Becker, Clara Bonnet, Anja Groth   +2 more
exaly  

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer

Annals of Oncology, 2020
Violeta Serra, S Nik-Zainal
exaly  

Homologous Recombination Deficiency and Ovarian Cancer Treatment Decisions

Surgical Pathology Clinics, 2022
Joseph T. Rabban, Lee-May Chen, W. Patrick Devine   +2 more
openaire   +1 more source

The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

Nature Reviews Molecular Cell Biology, 2020
Madalena Tarsounas, Patrick Sung
exaly  

RNA polymerase III is required for the repair of DNA double-strand breaks by homologous recombination

Cell, 2021
Sijie Liu, Junjie Yuan
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

Nature Reviews Molecular Cell Biology, 2010
Mary Ellen Moynahan, Maria Jasin
exaly